Evidence map›Paper›PMID 34797693›Full record

ArticleScience immunology2021

TWEAK functions with TNF and IL-17 on keratinocytes and is a potential target for psoriasis therapy.

Rinkesh K Gupta, Donald T Gracias, Daniela Salgado Figueroa, Haruka Miki, Jacqueline Miller, Kai Fung, Ferhat Ay, Linda Burkly, Michael Croft

Open access · greenAbstract read
In one paragraph

Article in Science immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
4.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 90 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Keratinocytes: pleiotropic orchestrators of cutaneous immunity and Inflammation - Emerging therapeutic paradigms in dermatological pathologies.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Circulating inflammatory proteins as pathogenic mediators and potential therapeutic targets in myasthenia gravis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Rinkesh K GuptaCenter for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.ORCID 0000-0002-1524-1347
Donald T GraciasCenter for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.
Daniela Salgado FigueroaCenter for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.ORCID 0000-0001-6476-7612
Haruka MikiCenter for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.
Jacqueline MillerCenter for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.
Kai FungBioinformatics Core, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.
Ferhat AyCenter for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.ORCID 0000-0002-0708-6914
Linda BurklyBiogen Inc., 115 Broadway, Cambridge, MA 02142, USA.
Michael CroftCenter for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.ORCID 0000-0002-6263-7256
La Jolla Institute for Immunology · USBiogen (United States) · US

Funding

TWEAK and Skin InflammationR01AR072640 · NIAMS · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI CROFT, MICHAEL · 2018 to 2022
$2.0M
NIAMS NIH HHS R01 AR072640
6 · The paper itself

Abstract

TNF and IL-17 are two cytokines that drive dysregulated keratinocyte activity, and their targeting is highly efficacious in patients with psoriasis, but whether these molecules act with other inflammatory factors is not clear. Here, we show that mice having a keratinocyte-specific deletion of Fn14 (

Indexed as

AnimalsCytokine TWEAKDisease Models, AnimalInterleukin-17KeratinocytesMaleMiceMice, Inbred C57BLMice, KnockoutPsoriasisTumor Necrosis FactorsCytokine TWEAKIl17a protein, mouseInterleukin-17Tnfsf12 protein, mouseTumor Necrosis Factors

Identifiers

PMID34797693
PMCPMC8756771
OpenAlexW3211613007

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.